Page 104 - 2023 Taiwan Food and Drug Administration Annual Report

2023 Taiwan Food and
Drug Administration

Annual Report

Appendix 1. Important Events
Jan
January 1 Four medical device inspecting institutions approved by the Food and
Drug Administration in our country and 6 European Notified Bodies (NBs)

officially signed TCP III, which would officially take effect on January

1, 2022; it allows medical device manufacturers in Taiwan and in the

EU to apply for expedited qualification of their medical device quality

Mar management systems.

March 8 The Taoyuan City Government held the “Launch Conference for the
Taoyuan Food Safety Information Platform” and the Director-General
of the Food and Drug Administration was invited to speak a few words

and preside over the opening ceremony. Businesses can spontaneously

release information about the origins of ingredients for foods prepared

on the platform and it is linked with TFDA’s systems (The Registration

Platform of Food and Medicinal Businesses, Food Traceability

Management Information System, PMDS) and the smart agriculture

shared information platform of the Council of Agriculture to provide people

with correct information on food safety.

March 17 The Taipei Bakery Association held the “Taipei International Bakery Show,”
May 5 which had more than 400 stands and multiple contests were organized
throughout the show. President Tsai and the Director-General appeared
MJunay June26 for the opening ceremony.

The OTN of the Executive Yuan had the “Taiwan-US TIFA Mid-term
Discussion Meeting” with the US.

TFDA held the “Pharmacist's Care: Safeguarding Medication Safety”
Fair in Taipei Expo park. The President and other distinguished guests
were invited to this event. TFDA, health departments from 17 towns, and
regional pharmacist associations collaborated to construct booths for the
event that were specifically focused on promoting medications. Through
interactive techniques, the booths educated the public about appropriate
pharmaceutical habits.

Jul June 28-30 TFDA attended the 16th ICCR meeting online as an official member to
exchange and share information with regulatory authorities and industries
102 July 11 through from 15 countries around the world. The meeting enabled TFDA to keep
August 11 track of cosmetics developments around the world and helped connect
Taiwan's cosmetics management system with the international community.

The manufacturing plant of TFDA for controlled drugs was approved
through the GMP review. It also received the manufacturing permit for
the additional solution formulation and drug permits for Methadone
Oral Concentrate and Morphine Sulfate Oral Solution. Mass production
successfully began for solutions.